These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 36368094)
1. Diverse limbic comorbidities cause limbic and temporal atrophy in lewy body disease. Sakurai K; Kaneda D; Morimoto S; Uchida Y; Inui S; Kimura Y; Cai C; Kato T; Ito K; Hashizume Y Parkinsonism Relat Disord; 2022 Dec; 105():52-57. PubMed ID: 36368094 [TBL] [Abstract][Full Text] [Related]
2. The influence of limbic-predominant age-related TDP-43 encephalopathy on argyrophilic grain disease: A voxel-based morphometry analysis of pathologically confirmed cases. Inui S; Kaneda D; Sakurai K; Morimoto S; Uchida Y; Abe O; Hashizume Y J Neurol Sci; 2024 Feb; 457():122894. PubMed ID: 38266517 [TBL] [Abstract][Full Text] [Related]
3. Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease. Ferman TJ; Arvanitakis Z; Fujishiro H; Duara R; Parfitt F; Purdy M; Waters C; Barker W; Graff-Radford NR; Dickson DW Parkinsonism Relat Disord; 2013 Feb; 19(2):227-31. PubMed ID: 23182311 [TBL] [Abstract][Full Text] [Related]
4. Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease. Uemura MT; Robinson JL; Cousins KAQ; Tropea TF; Kargilis DC; McBride JD; Suh E; Xie SX; Xu Y; Porta S; Uemura N; Van Deerlin VM; Wolk DA; Irwin DJ; Brunden KR; Lee VM; Lee EB; Trojanowski JQ Acta Neuropathol; 2022 Jan; 143(1):15-31. PubMed ID: 34854996 [TBL] [Abstract][Full Text] [Related]
5. The development and convergence of co-pathologies in Alzheimer's disease. Robinson JL; Richardson H; Xie SX; Suh E; Van Deerlin VM; Alfaro B; Loh N; Porras-Paniagua M; Nirschl JJ; Wolk D; Lee VM; Lee EB; Trojanowski JQ Brain; 2021 Apr; 144(3):953-962. PubMed ID: 33449993 [TBL] [Abstract][Full Text] [Related]
6. Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes. Boon BDC; Labuzan SA; Peng Z; Matchett BJ; Kouri N; Hinkle KM; Lachner C; Ross OA; Ertekin-Taner N; Carter RE; Ferman TJ; Duara R; Dickson DW; Graff-Radford NR; Murray ME Neurology; 2023 Oct; 101(14):e1412-e1423. PubMed ID: 37580158 [TBL] [Abstract][Full Text] [Related]
7. The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer's dementia in older persons. Agrawal S; Yu L; Nag S; Arfanakis K; Barnes LL; Bennett DA; Schneider JA Acta Neuropathol Commun; 2021 Sep; 9(1):156. PubMed ID: 34563269 [TBL] [Abstract][Full Text] [Related]
8. Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology. Ryman SG; Yutsis M; Tian L; Henderson VW; Montine TJ; Salmon DP; Galasko D; Poston KL J Alzheimers Dis; 2021; 80(3):1243-1256. PubMed ID: 33646154 [TBL] [Abstract][Full Text] [Related]
12. Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Nedelska Z; Ferman TJ; Boeve BF; Przybelski SA; Lesnick TG; Murray ME; Gunter JL; Senjem ML; Vemuri P; Smith GE; Geda YE; Graff-Radford J; Knopman DS; Petersen RC; Parisi JE; Dickson DW; Jack CR; Kantarci K Neurobiol Aging; 2015 Jan; 36(1):452-61. PubMed ID: 25128280 [TBL] [Abstract][Full Text] [Related]
13. Voxel-Based and Surface-Based Morphometry Analysis in Patients with Pathologically Confirmed Argyrophilic Grain Disease and Alzheimer's Disease. Sakurai K; Kaneda D; Morimoto S; Uchida Y; Inui S; Kimura Y; Kan H; Kato T; Ito K; Hashizume Y J Alzheimers Dis; 2023; 93(1):379-387. PubMed ID: 37005887 [TBL] [Abstract][Full Text] [Related]
14. Neuropathological associations of limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) differ between the oldest-old and younger-old. Wang SJ; Guo Y; Ervin JF; Lusk JB; Luo S Acta Neuropathol; 2022 Jul; 144(1):45-57. PubMed ID: 35551470 [TBL] [Abstract][Full Text] [Related]
15. Diffuse Lewy body disease presenting as Parkinson's disease with progressive aphasia. Koga S; Murakami A; Josephs KA; Dickson DW Neuropathology; 2022 Feb; 42(1):82-89. PubMed ID: 35029300 [TBL] [Abstract][Full Text] [Related]
16. TDP-43 is associated with a reduced likelihood of rendering a clinical diagnosis of dementia with Lewy bodies in autopsy-confirmed cases of transitional/diffuse Lewy body disease. Buciuc M; Whitwell JL; Boeve BF; Ferman TJ; Graff-Radford J; Savica R; Kantarci K; Fields JA; Knopman DS; Petersen RC; Parisi JE; Murray ME; Dickson DW; Josephs KA J Neurol; 2020 May; 267(5):1444-1453. PubMed ID: 32006160 [TBL] [Abstract][Full Text] [Related]
17. Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases. Jellinger KA J Neural Transm (Vienna); 2021 May; 128(5):687-699. PubMed ID: 33928445 [TBL] [Abstract][Full Text] [Related]
19. Pure argyrophilic grain disease revisited: independent effects on limbic, neocortical, and striato-pallido-nigral degeneration and the development of dementia in a series with a low to moderate Braak stage. Yokota O; Miki T; Nakashima-Yasuda H; Ishizu H; Haraguchi T; Ikeda C; Hasegawa M; Miyashita A; Ikeuchi T; Nishikawa N; Takenoshita S; Sudo K; Terada S; Takaki M Acta Neuropathol Commun; 2024 Jul; 12(1):121. PubMed ID: 39085955 [TBL] [Abstract][Full Text] [Related]
20. Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem. Yokota O; Tsuchiya K; Uchihara T; Ujike H; Terada S; Takahashi M; Kimura Y; Ishizu H; Akiyama H; Kuroda S Neuropathology; 2007 Feb; 27(1):21-35. PubMed ID: 17319280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]